Nrf2 regulators

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10485806
APP PUB NO 20190224212A1
SERIAL NO

16375047

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to aryl analogs, pharmaceutical compositions containing them and their use as NRF2 regulators.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ASTEX THERAPEUTICS LIMITEDCAMBRIDGE CAMBRIDGESHIRE CB4 0QA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Boehm, Jeffrey Charles King of Prussia, US 32 496
Callahan, James Francis King of Prussia, US 35 169
Heightman, Thomas Daniel Hertfordshire, GB 48 214
Kerns, Jeffrey K King of Prussia, US 30 157
Woolford, Alison Jo-Anne Cambridgeshire, GB 46 452
Yan, Hongxing King of Prussia, US 30 131

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 26, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 26, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00